Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed, along with removal of a government funding operating-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding lapse notice indicating the NIH Clinical Center is open, and updated the page revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

- Check28 days agoChange DetectedThe page history adds a 'Show glossary' option and color-coded change highlights (green for additions, red for deletions). The revision label updates from v3.3.4 to v3.4.0.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the v3.3.3 entry was removed; no study data or statuses appear to change.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry Revision: v3.3.3 was added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, and the previous revision v3.3.1 was removed.SummaryDifference0.1%

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.